Alpha Cognition Inc Market Cap ($127.19 Million)
Market Cap & Net Worth: Alpha Cognition Inc (ACOG)
Alpha Cognition Inc market cap. Alpha Cognition Inc (NASDAQ:ACOG) has a market capitalization of $127.19 Million ($127.19 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18076 globally and #4248 in its home market, demonstrating a -1.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alpha Cognition Inc's stock price $8.20 by its total outstanding shares 21742104 (21.74 Million). Also see ACOG cash flow metrics for how efficiently the company converts equity into cash flow.
Alpha Cognition Inc Market Cap History (2015–2026)
Alpha Cognition Inc market cap history from 2015 to 2026. Data shows change from $520.98 Million to $178.29 Million (-7.74% CAGR). Check ACOG stock price for real-time trading data and today's change.
Index Memberships
Alpha Cognition Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #491 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1744 of 3165 |
Weight: Alpha Cognition Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alpha Cognition Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alpha Cognition Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ACOG year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ACOG by Market Capitalization
Companies near Alpha Cognition Inc in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Alpha Cognition Inc for a full breakdown of the balance sheet.
Key companies related to Alpha Cognition Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Alpha Cognition Inc (2015–2026)
Market capitalization of Alpha Cognition Inc from 2015 to today. Between 2015 and today, Alpha Cognition Inc's market cap moved from $520.98 Million to $ 178.29 Million, with a yearly change of -7.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $178.29 Million | +26.15% |
| 2025 | $141.32 Million | +10.36% |
| 2024 | $128.06 Million | -80.69% |
| 2018 | $663.13 Million | +7.38% |
| 2017 | $617.58 Million | +9.67% |
| 2016 | $563.12 Million | +8.09% |
| 2015 | $520.98 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Alpha Cognition Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $127.19 Million USD |
| MoneyControl | $127.19 Million USD |
| MarketWatch | $127.19 Million USD |
| marketcap.company | $127.19 Million USD |
| Reuters | $127.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alpha Cognition Inc
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatm… Read more